Warburg in 3M Pharma Hunt

3M is considering a sale of its pharmaceuticals division (mostly generics), according to The Economic Times. The paper reports that the deal could be worth up to $1 billion, with likely suitors including Warburg Pincus and Indian drug companies Ranbaxy and Wockhardt. www.3m.com